Literature DB >> 18256070

Autopsy findings in 42 consecutive patients with idiopathic pulmonary fibrosis.

C E Daniels1, E S Yi, J H Ryu.   

Abstract

Idiopathic pulmonary fibrosis (IPF) is a relentlessly progressive lung disease that commonly results in respiratory failure and death. However, the cause of death in these patients has not previously been fully defined. The current study reviews the clinical records and pathological findings of 42 consecutive patients with IPF who underwent a post mortem at the Mayo Clinic (Rochester, MN, USA) over a 9-yr period, from January 1996 to December 2004. The median (range) age at post mortem for the patients was 74 (46-98 yrs) yrs, which included 25 (60%) males. A total of 31 (74%) patients died in the hospital. The immediate causes of death were reported as: respiratory (64%), cardiovascular (21%), or noncardiopulmonary (14%). Acute exacerbation of IPF was the most common immediate cause of death (29%). Pneumonia, aspiration and drug-induced lung disease were identified as other causes of respiratory death. Evidence of pulmonary hypertension was present in the post mortem of 19 (45%) patients and was the immediate cause of death in two of these patients. The immediate cause of death was clinically unsuspected in five (12%) patients and IPF was diagnosed post mortem in nine (21%) patients. The majority of patients with idiopathic pulmonary fibrosis who had undergone a post mortem were found to have died from respiratory causes. Acute exacerbation of idiopathic pulmonary fibrosis was found to be the most common cause of death whilst death from the gradual progression of idiopathic pulmonary fibrosis was found to be less common.

Entities:  

Mesh:

Year:  2008        PMID: 18256070     DOI: 10.1183/09031936.00176307

Source DB:  PubMed          Journal:  Eur Respir J        ISSN: 0903-1936            Impact factor:   16.671


  24 in total

1.  Increased platelet binding to circulating monocytes in idiopathic pulmonary fibrosis.

Authors:  Ahmed Fahim; Michael G Crooks; Alyn H Morice; Simon P Hart
Journal:  Lung       Date:  2014-01-07       Impact factor: 2.584

2.  Evaluation of circulating YKL-40 levels in idiopathic interstitial pneumonias.

Authors:  Nicoline M Korthagen; Coline H M van Moorsel; Pieter Zanen; Henk J Ruven; Jan C Grutters
Journal:  Lung       Date:  2014-10-02       Impact factor: 2.584

Review 3.  High-resolution CT of complications of idiopathic fibrotic lung disease.

Authors:  C R Lloyd; S L F Walsh; D M Hansell
Journal:  Br J Radiol       Date:  2011-07       Impact factor: 3.039

4.  A retrospective study of prognostic factors in patients with interstitial pneumonia receiving long-term oxygen therapy.

Authors:  Masayoshi Higashiguchi; Takashi Kijima; Hiromitsu Sumikawa; Osamu Honda; Toshiyuki Minami; Haruhiko Hirata; Koji Inoue; Izumi Nagatomo; Yoshito Takeda; Hiroshi Kida; Noriyuki Tomiyama; Atsushi Kumanogoh
Journal:  Lung       Date:  2014-07-24       Impact factor: 2.584

5.  Seasonal variation: mortality from pulmonary fibrosis is greatest in the winter.

Authors:  Amy L Olson; Jeffrey J Swigris; Ganesh Raghu; Kevin K Brown
Journal:  Chest       Date:  2008-08-08       Impact factor: 9.410

6.  Impairment of right ventricular strain evaluated by cardiovascular magnetic resonance feature tracking in patients with interstitial lung disease.

Authors:  Hiroyuki Kamide; Shingo Kato; Keigo Hayakawa; Kazuki Fukui; Hideya Kitamura; Takashi Ogura; Tae Iwasawa; Kazuo Kimura; Kouichi Tamura; Daisuke Utsunomiya
Journal:  Int J Cardiovasc Imaging       Date:  2020-10-28       Impact factor: 2.357

7.  Postoperative Acute Exacerbation of IPF after Lung Resection for Primary Lung Cancer.

Authors:  Atsushi Watanabe; Nobuyoshi Kawaharada; Tetsuya Higami
Journal:  Pulm Med       Date:  2011-02-07

8.  KD025 Shifts Pulmonary Endothelial Cell Bioenergetics and Decreases Baseline Lung Permeability.

Authors:  Ji Young Lee; Reece P Stevens; Mary Kash; Chun Zhou; Anna Koloteva; Phoibe Renema; Sunita S Paudel; Troy Stevens
Journal:  Am J Respir Cell Mol Biol       Date:  2020-10       Impact factor: 6.914

9.  Frequency and Significance of Pathologic Pulmonary Findings in Postmortem Examinations-A Single Center Experience before COVID-19.

Authors:  Sabina Berezowska; Andreas Schmid; Tereza Losmanová; Mafalda Trippel; Annika Blank; Yara Banz; Stephan M Jakob; Rupert Langer
Journal:  Diagnostics (Basel)       Date:  2021-05-18

10.  Procalcitonin-guided antibiotic use in acute exacerbations of idiopathic pulmonary fibrosis.

Authors:  Juanjuan Ding; Zhuochang Chen; Keqing Feng
Journal:  Int J Med Sci       Date:  2013-05-20       Impact factor: 3.738

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.